Sunfox raises $7M Series A for cardiac diagnostics platform

Dehradun-based medtech startup Sunfox Technologies has raised $7 million (₹67 crore) in a Series A round led by an unnamed investor to scale its portable cardiac diagnostics platform, Spandan. The funding was reported earlier this week.

Spandan is described as a pocket-sized device designed for use in clinics, pharmacies, and rural health centers. The startup suggests it can detect a range of cardiac conditions, with results delivered quickly. Sunfox aims to address India’s primary care gap, where access to cardiologists and diagnostic equipment is often limited outside urban centers.

The funding reflects a broader trend of healthtech investors backing hardware-enabled diagnostics in emerging markets. While telemedicine and AI-driven imaging have attracted significant funding recently, Sunfox’s focus on a low-cost, portable device highlights demand for solutions that could bridge gaps in primary care. The Series A follows a period of adoption, with reports suggesting Spandan has gained traction in clinics across India, though financial details remain undisclosed.

Competition in the portable diagnostics space is growing, with other players also expanding in India. Sunfox’s path forward will depend on scaling manufacturing and distribution while ensuring accuracy and regulatory compliance. The startup has not shared details about its regulatory status or potential international expansion.

The $7 million round size suggests cautious investor interest in hardware-heavy healthtech in India, where challenges like unit economics and sales cycles persist. Success will likely hinge on reducing device costs and expanding beyond clinics into broader distribution channels. For now, the funding provides a runway to test its model in a market where cardiac disease remains a major health concern.

Sources: inc42.com